GSK sues Patent Office to protect pending applications

10/15/2007 | International Herald Tribune · Wall Street Journal, The

GlaxoSmithKline has filed charges against the U.S. Patent and Trademark Office for imposing new rules that would allegedly damage around 100 of the drug giant's unapproved patent applications. The PTO said the new rules, which take effect Nov. 1, would make patent application more "efficient by encouraging applicants to use greater precision in describing the scope of their inventions." A GSK spokeswoman said the regulations would "stifle innovation because they would severely limit our ability to fully claim our inventions."

View Full Article in:

International Herald Tribune · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO